Pharma Controls Clinical Trials of Their Drugs. Is This Hazardous to Your Health?

Forbes argues the wisdom of allowing drug companies to run their own clinical trials. After citing multiple sources decrying this practice, John LaMattina points out that the FDA weighs in heavily in the design and administration of trials and can refuse to review a resulting NDA.
Forbes